APA (7th ed.) Citation

Lo, S., Hendifar, A., Sharma, N., Othman, M., Mendoza-Ladd, A., Verco, S., . . . diZerega, G. (2019). 6 A Novel EUS-Guided Intratumoral Delivery of Submicron Particle Paclitaxel (SPP) for the Treatment of Locally Advanced Pancreatic Cancer (LA-PAC): A Prospective Safety, Tolerability and Preliminary Efficiency Study. The American journal of gastroenterology, 114(1), S3-S4. https://doi.org/10.14309/01.ajg.0000589556.41054.b3

Chicago Style (17th ed.) Citation

Lo, Simon, Andrew Hendifar, Neil Sharma, Mohamed Othman, Antonio Mendoza-Ladd, Shelagh Verco, James Verco, and Gere diZerega. "6 A Novel EUS-Guided Intratumoral Delivery of Submicron Particle Paclitaxel (SPP) for the Treatment of Locally Advanced Pancreatic Cancer (LA-PAC): A Prospective Safety, Tolerability and Preliminary Efficiency Study." The American Journal of Gastroenterology 114, no. 1 (2019): S3-S4. https://doi.org/10.14309/01.ajg.0000589556.41054.b3.

MLA (9th ed.) Citation

Lo, Simon, et al. "6 A Novel EUS-Guided Intratumoral Delivery of Submicron Particle Paclitaxel (SPP) for the Treatment of Locally Advanced Pancreatic Cancer (LA-PAC): A Prospective Safety, Tolerability and Preliminary Efficiency Study." The American Journal of Gastroenterology, vol. 114, no. 1, 2019, pp. S3-S4, https://doi.org/10.14309/01.ajg.0000589556.41054.b3.